{"id":"W2314059412","doi":"10.1136/ejhpharm-2013-000436.208","title":"DI-037 Comparison of indirect treatment for first-line metastatic pancreatic cancer: Abstract DI-037 Table 1","year":2014,"lang":"en","type":"article","venue":"European Journal of Hospital Pharmacy","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"FOLFIRINOX; Gemcitabine; Medicine; Erlotinib; Oncology; Internal medicine; Pancreatic cancer; Population; Hazard ratio; Oxaliplatin; Confidence interval; Cancer; Epidermal growth factor receptor; Colorectal cancer","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00331844,0.0009781711,0.003423843,0.001961852,0.0002406305,0.001308413,0.0008308462,0.0007496433,0.0662564],"category_scores_gemma":[0.006381908,0.0002787976,0.00491692,0.002746435,0.0002190294,0.0006629425,0.0005066084,0.00121237,0.003661274],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001293274,"about_ca_system_score_gemma":0.001715421,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008493621,"about_ca_topic_score_gemma":0.002876812,"domain_scores_codex":[0.9963176,0.001732151,0.0009283521,0.0002806044,0.0006281817,0.0001131575],"domain_scores_gemma":[0.9959825,0.00207094,0.0008373566,0.0002007053,0.0006642267,0.0002442987],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","study_design_scores_codex":[0.3757338,0.001210666,0.006002828,0.1979824,0.03902542,0.0001958287,0.00007386984,0.001210113,0.008209534,0.002831883,0.06807991,0.2994437],"study_design_scores_gemma":[0.3636699,0.06616702,0.07600981,0.02810701,0.09956846,0.0009290015,0.0002413161,0.001286449,0.008911331,0.004387367,0.3505169,0.0002053016],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"other","genre_scores_codex":[0.1059895,0.4713194,0.007527834,0.005584863,0.007842098,0.04250392,0.2619129,0.000905192,0.09641435],"genre_scores_gemma":[0.4992583,0.214909,0.02005981,0.01388764,0.004149038,0.0395433,0.1488604,0.0004174397,0.05891512],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.0662564,"threshold_uncertainty_score":0.2216498,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08622662382313773,"score_gpt":0.4059243558646035,"score_spread":0.3196977320414658,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}